Hwang Woo-Suk is continuing his comeback. According to Nature News, Hwang has applied for a new license to work with human embryonic stem cells. The Korean science ministry is scheduled to decide on that license by this coming April. Hwang is still on trial for fraud, embezzlement, and for breaches of bioethics laws.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.